Amgen (AMGN) Insider Trading & Ownership $279.31 +2.18 (+0.79%) As of 10:31 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Amgen (NASDAQ:AMGN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.69%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$21.08M Get AMGN Insider Trade Alerts Want to know when executives and insiders are buying or selling Amgen stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address AMGN Insider Buying and Selling by Quarter Amgen Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/5/2025Rachna KhoslaSVPSell1,500$289.68$434,520.00 5/14/2025Marjorie Taylor GreeneU.S. Congress Member (R-GA)Buy$262.28$1,001 - $15,0005/5/2025Marjorie Taylor GreeneU.S. Congress Member (R-GA)Buy$280.06$1,001 - $15,0004/16/2025Jared MoskowitzU.S. Congress Member (D-FL)Buy$282.64$1,001 - $15,0004/15/2025Tommy TubervilleU.S. Congress Member (R-AL)Sell$295.30$15,001 - $50,0004/11/2025Jefferson ShreveU.S. Congress Member (R-IN)Buy$285.98$15,001 - $50,0004/9/2025Ro KhannaU.S. Congress Member (D-CA)Buy$291.09$1,001 - $15,0004/8/2025Robert Bresnahan, Jr.U.S. Congress Member (R-PA)Sell$280.26$1,001 - $15,0002/24/2025Jefferson ShreveU.S. Congress Member (R-IN)Buy$309.72$15,001 - $50,0002/21/2025David M ReeseEVPSell25,225$304.44$7,679,499.00 2/19/2025David M ReeseEVPSell8,711$293.22$2,554,239.42 2/11/2025Murdo GordonEVPSell8,771$294.79$2,585,603.09 2/7/2025Jonathan P GrahamEVPSell25,045$293.12$7,341,190.40 2/5/2025Nancy A GrygielSVPSell1,589$304.47$483,802.83 (Data available from 1/1/2013 forward) AMGN Insider Trading Activity - Frequently Asked Questions Who is on Amgen's Insider Roster? The list of insiders at Amgen includes Amgen Inc, David M Reese, Jonathan P Graham, Murdo Gordon, Nancy A Grygiel, R Sanders Williams, Rachna Khosla, and Robert Eckert. Learn more on insiders at AMGN. What percentage of Amgen stock is owned by insiders? 0.69% of Amgen stock is owned by insiders. Learn more on AMGN's insider holdings. Which Amgen insiders have been buying company stock? The following insider purchased AMGN shares in the last 24 months: Amgen Inc ($29,999,985.00). How much insider buying is happening at Amgen? Insiders have purchased a total of 1,764,705 AMGN shares in the last 24 months for a total of $29,999,985.00 bought. Which Amgen insiders have been selling company stock? The following insiders have sold AMGN shares in the last 24 months: David M Reese ($10,233,738.42), Jonathan P Graham ($10,069,290.40), Murdo Gordon ($5,093,909.03), Nancy A Grygiel ($1,718,885.24), and Rachna Khosla ($434,520.00). How much insider selling is happening at Amgen? Insiders have sold a total of 94,612 Amgen shares in the last 24 months for a total of $27,550,343.09 sold. Which members of congress are trading Amgen? Marjorie Taylor Greene (R-GA), Jared Moskowitz (D-FL), Jefferson Shreve (R-IN), Ro Khanna (D-CA), Virginia Foxx (R-NC), C. Scott Franklin (R-FL), and Kathy E. Manning (D-NC) have bought shares of Amgen in the last year totaling $196,000. Tommy Tuberville (R-AL), Robert Bresnahan, Jr. (R-PA), Emily Randall (D-WA), and Sheldon Whitehouse (D-RI) have sold shares totaling $56,500. Amgen Key ExecutivesMr. Robert A. Bradway (Age 61)Chairman & Chief Executive Officer Compensation: $6.73MMr. Peter H. Griffith (Age 65)Executive VP & CFO Compensation: $3.07MMr. Esteban Santos (Age 56)Executive Vice President of Operations Compensation: $3.01MDr. David M. Reese M.D. (Age 61)Executive VP & Chief Technology Officer Compensation: $3.4MMr. Murdo Gordon (Age 57)Executive Vice President of Global Commercial Operations Compensation: $3.24M1 recent tradesMr. Matthew C. Busch (Age 50)Chief Accounting Officer & VP of Finance Mr. Mike ZahigianSenior VP & Chief Information OfficerDr. James E. Bradner M.D. (Age 52)Executive VP of Research and Development & Chief Scientific Officer Justin G. ClaeysVice President of Investor RelationsMr. Jonathan P. Graham (Age 63)Executive VP, General Counsel & Secretary Compensation: $2.44M1 recent trades More Insider Trading Tools from MarketBeat Related Companies Gilead Sciences Insider Ownership Vertex Pharmaceuticals Insider Ownership Regeneron Pharmaceuticals Insider Ownership Alnylam Pharmaceuticals Insider Ownership Biogen Insider Ownership Incyte Insider Ownership United Therapeutics Insider Ownership Neurocrine Biosciences Insider Ownership Exelixis Insider Ownership BioMarin Pharmaceutical Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Hot Trades for Insiders, But Are They Good Buys for Investors?Insiders Chase Income and Stability in American Tower—Here’s Why3 Tech Stocks With High and Rising Institutional Interest3 Summer Stocks With Insider Buying and Analyst Support3 Tightly-Held Growth Stocks Set Up for Short Squeezes This page (NASDAQ:AMGN) was last updated on 6/30/2025 by MarketBeat.com Staff From Our PartnersThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe Recession Already Started, Are You Prepared?Global central banks are stockpiling gold. Billionaires are hedging with precious metals. And thousands of Ame...Lear Capital | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amgen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amgen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AMGN Stock Alerts